Furthermore, the combined therapy applied here of MSCs and PIO reduced apoptosis in the heart in diabetes as evident by lowering levels of pro-apoptotic markers i.e. caspase-3, cleaved caspase-3 and Bax and increasing the levels of anti-apoptotic marker, Bcl-2 in the heart of diabetic rats. This evidence concerns the gene CASP3 and diabetes mellitus.